T cell therapists
Dr Hong Zhan
Dr Hong Zhan led production of retroviral modified T cells for a Phase 1 study of suicide gene modified T cells. She has experience in GMP production of vector stock and T cell engineering and heading translation of up-coming TCR and CAR engineered cells
Dr Christos Georgiadis
Christos studied gene therapy for EB for his PhD with our group and then picked up projects for genome edited T cell therapies, including CAR-T cells for leukaemia and the application of cord blood cells.
Annie is investigating strategies to edit T cells using lentiviral vectors and CRISPR/Cas9
Dr Lauren Nickolay
Lauren is developing ways to improve T cell engineering for clinical therapies, including automation of the processes.
Roland studied for his MSc and is now a PhD student investigating strategies to improved CRISPR/Cas9 genome editing
Dr Syed Farhatullah
Samir is a post doctoral researcher with GMP exerptise in CAR19 T cells